{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:46:28Z","timestamp":1786981588618,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s11102-024-01382-3","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T06:02:18Z","timestamp":1707717738000},"page":"204-212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Elevated risk of recurrence and retreatment for silent pituitary adenomas"],"prefix":"10.1007","volume":"27","author":[{"given":"Saksham","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha E.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel H.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelle","family":"Altshuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Bernstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Arnaout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward R.","family":"Laws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"key":"1382_CR1","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1210\/jc.2011-0168","volume":"96","author":"P Famini","year":"2011","unstructured":"Famini P, Maya MM, Melmed S (2011) Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab 96:1633\u20131641","journal-title":"J Clin Endocrinol Metab"},{"key":"1382_CR2","first-page":"319","volume":"88","author":"MG Lake","year":"2013","unstructured":"Lake MG, Krook LS, Cruz SV (2013) Pituitary adenomas: an overview. Am Fam Physician 88:319\u2013327","journal-title":"Am Fam Physician"},{"key":"1382_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","volume":"49","author":"AF Daly","year":"2020","unstructured":"Daly AF, Beckers A (2020) The epidemiology of Pituitary Adenomas. Endocrinol Metab Clin North Am 49:347\u2013355","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1382_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cncr.20412","volume":"101","author":"S Ezzat","year":"2004","unstructured":"Ezzat S, Asa SL, Couldwell WT et al (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101:613\u2013619","journal-title":"Cancer"},{"key":"1382_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1530\/EJE-10-0255","volume":"163","author":"S Brochier","year":"2010","unstructured":"Brochier S, Galland F, Kujas M et al (2010) Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients. Eur J Endocrinol 163:193\u2013200","journal-title":"Eur J Endocrinol"},{"key":"1382_CR6","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.wneu.2014.03.031","volume":"82","author":"MA Kirkman","year":"2014","unstructured":"Kirkman MA, Jaunmuktane Z, Brandner S et al (2014) Active and silent thyroid-stimulating hormone-expressing pituitary adenomas: presenting symptoms, treatment, outcomes, and recurrence. World Neurosurg 82:1224\u20131231","journal-title":"World Neurosurg"},{"key":"1382_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12022-009-9094-y","volume":"20","author":"EL Wang","year":"2009","unstructured":"Wang EL, Qian ZR, Yamada S et al (2009) Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas. Endocr Pathol 20:209\u2013220","journal-title":"Endocr Pathol"},{"key":"1382_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.beem.2012.01.002","volume":"26","author":"O Cooper","year":"2012","unstructured":"Cooper O, Melmed S (2012) Subclinical hyperfunctioning pituitary adenomas: the silent tumors. Best Pract Res Clin Endocrinol Metab 26:447","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1382_CR9","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3171\/2020.2.JNS2018","volume":"134","author":"A Micko","year":"2020","unstructured":"Micko A, R\u00f6tzer T, Hoftberger R et al (2020) Expression of additional transcription factors is of prognostic value for aggressive behavior of pituitary adenomas. J Neurosurg 134:1139\u20131146","journal-title":"J Neurosurg"},{"key":"1382_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12022-017-9503-6","volume":"28","author":"JC Lee","year":"2017","unstructured":"Lee JC, Pekmezci M, Lavezo JL et al (2017) Utility of Pit-1 immunostaining in distinguishing pituitary adenomas of primitive differentiation from null cell adenomas. Endocr Pathol 28:287\u2013292","journal-title":"Endocr Pathol"},{"key":"1382_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"Trouillas J, Roy P, Sturm N et al (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126:123\u2013135","journal-title":"Acta Neuropathol"},{"key":"1382_CR12","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3390\/brainsci12081002","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Li M, Jiang X et al (2022) Prediction of higher Ki-67 index in Pituitary Adenomas by pre- and intra-operative clinical characteristics. Brain Sci 12:1002","journal-title":"Brain Sci"},{"key":"1382_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO classification of Pituitary tumors. Endocr Pathol 33:6\u201326","journal-title":"Endocr Pathol"},{"key":"1382_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"Lopes MBS (2017) The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134:521\u2013535","journal-title":"Acta Neuropathol"},{"key":"1382_CR15","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1210\/jc.2018-00688","volume":"104","author":"J Drummond","year":"2019","unstructured":"Drummond J, Roncaroli F, Grossman AB, Korbonits M (2019) Clinical and pathological aspects of Silent Pituitary Adenomas. J Clin Endocrinol Metab 104:2473\u20132489","journal-title":"J Clin Endocrinol Metab"},{"key":"1382_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME (2017) Diagnosis and treatment of Pituitary adenomas: a review. JAMA 317:516\u2013524","journal-title":"JAMA"},{"key":"1382_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11102-011-0347-7","volume":"15","author":"F Roelfsema","year":"2012","unstructured":"Roelfsema F, Biermasz NR, Pereira AM (2012) Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15:71\u201383","journal-title":"Pituitary"},{"key":"1382_CR18","doi-asserted-by":"publisher","unstructured":"Lu L, Wan X, Xu Y et al (2022) Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions. Diagnostics (Basel) 12.: https:\/\/doi.org\/10.3390\/diagnostics12040977","DOI":"10.3390\/diagnostics12040977"},{"key":"1382_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s11102-011-0350-z","volume":"15","author":"CP Hofstetter","year":"2012","unstructured":"Hofstetter CP, Nanaszko MJ, Mubita LL et al (2012) Volumetric classification of pituitary macroadenomas predicts outcome and morbidity following endoscopic endonasal transsphenoidal surgery. Pituitary 15:450\u2013463","journal-title":"Pituitary"},{"key":"1382_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.14310\/horm.2002.1409","volume":"12","author":"KI Lampropoulos","year":"2013","unstructured":"Lampropoulos KI, Samonis G, Nomikos P (2013) Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients. Hormones 12:254\u2013264","journal-title":"Hormones"},{"key":"1382_CR21","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1590\/S0004-282X2005000600029","volume":"63","author":"JEA Ferreira","year":"2005","unstructured":"Ferreira JEA, de Mello PA, de Magalh\u00e3es AV et al (2005) [Non-functioning pituitary adenomas: clinical features and immunohistochemistry]. Arq Neuropsiquiatr 63:1070\u20131078","journal-title":"Arq Neuropsiquiatr"},{"key":"1382_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/cen.13365","volume":"87","author":"AK Watts","year":"2017","unstructured":"Watts AK, Easwaran A, McNeill P et al (2017) Younger age is a risk factor for regrowth and recurrence of nonfunctioning pituitary macroadenomas: results from a single Australian centre. Clin Endocrinol 87:264\u2013271","journal-title":"Clin Endocrinol"},{"key":"1382_CR23","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/jnen\/nlx072","volume":"76","author":"TE Richardson","year":"2017","unstructured":"Richardson TE, Shen Z-J, Kanchwala M et al (2017) Aggressive behavior in Silent Subtype III Pituitary Adenomas May depend on suppression of local Immune response: a whole transcriptome analysis. J Neuropathol Exp Neurol 76:874\u2013882","journal-title":"J Neuropathol Exp Neurol"},{"key":"1382_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/modpathol.2015.151","volume":"29","author":"O Mete","year":"2016","unstructured":"Mete O, Gomez-Hernandez K, Kucharczyk W et al (2016) Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas. Mod Pathol 29:131\u2013142","journal-title":"Mod Pathol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01382-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01382-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01382-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T04:33:40Z","timestamp":1712896420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01382-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1382"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01382-3","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,12]]},"assertion":[{"value":"31 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research study was conducted retrospectively from data obtained for clinical purposes. There are no personal identifying details of any patients in this manuscript. For retrospective de-identified clinical research, patients are given the ability to opt-out when they are admitted at our institution. To the study authors\u2019 best knowledge, all patients approved of use of their de-identified clinical data. This study was approved under Mass General Brigham IRB Protocol #2015P002352.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"JDB has an equity position in Treovir Inc., an oHSV clinical stage company and is a member of the POCKiT Diagnostics, Centile Bioscience, and NeuroX1 Boards of Scientific Advisors. All other authors report no disclosures or conflicts of interest related to this submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}